Loading company…
Riskpilot
← Back to search
Sign in
Get full access
NectarCph IVS
IVS
Dissolved
CVR 38720252
Nordvestvej 16
Activities of advertising agencies · NACE 7311
Est. 2017
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2021
DKK 203K
+57% vs 2020
EBITDA margin
26.3%
+146% vs 2020
Equity ratio
-51.8%
Financial strength
Net profit 2021
DKK 28K
+130% vs 2020
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
0M
2018
0M
0%
2019
0M
0%
2020
0M
0%
2021
Key figures
Annual report 2021
Revenue
DKK 203K
+57%
EBITDA
DKK 53K
+146%
Net profit
DKK 28K
+130%
Total assets
DKK 99K
+113%
Equity
DKK -51K
+35%
Employees
1
—
Company information
Legal name
NectarCph IVS
CVR number
38720252
Legal form
Iværksætterselskab
NACE code
7311 · Activities of advertising agencies
Founded
18. juni 2017
Share capital
DKK 1
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2021-06-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktionen.
Contact
Address
Nordvestvej 16
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Activities of advertising agencies
Companies in Kalundborg
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
0M
2021
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2018
0M
2019
0M
2020
0M
2021
Income statement
DKK thousands
Item
2018
2019
2020
2021
Revenue
47
396
129
203
Staff expenses
-45
-375
-244
-150
EBITDA
2
21
-115
53
Depreciation & amort.
-0
-0
-0
-0
EBIT
2
21
-115
53
Net financials
-1
-2
1
-2
Profit before tax
1
19
-115
51
Tax
1
7
-24
24
Net profit
-0
12
-91
28
Balance sheet
DKK thousands
Item
2018
2019
2020
2021
Total assets
92
67
46
99
Equity
-0
12
-79
-51
Long-term debt
0
0
0
0
Short-term debt
92
55
125
150
Total debt
92
55
125
150
Financial ratios
5-year trend
EBITDA margin
26.3%
This company
15.8%
Market median
+66% vs market
2018
2021
Equity ratio
-51.8%
This company
38.2%
Market median
-236% vs market
2018
2021
Return on equity
2751200.0%
This company
18.4%
Market median
+14952074% vs market
2018
2021
Net profit margin
13.6%
This company
8.1%
Market median
+68% vs market
2018
2021
Asset turnover
2.06×
This company
1.12×
Market median
+84% vs market
2018
2021
Debt / equity
2.93×
This company
0.62×
Market median
-373% vs market
2018
2021
Annual reports & filings
Annual report 2021
Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2019-07-01 – 2020-06-30
View
PDF
Annual report 2019
Filed via CVR / Virk · Period 2018-07-01 – 2019-06-30
View
PDF
Annual report 2018
Filed via CVR / Virk · Period 2017-06-18 – 2018-06-30
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Xenia Dinah Nedergaard
Individual
100.0%
100.0%
2017
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of NectarCph IVS also hold positions in
0
other companies.
Person
Role here
Other companies